HIV-1 ENV FUSION PEPTIDE IMMUNOGENS AND THEIR USE Read more about HIV-1 ENV FUSION PEPTIDE IMMUNOGENS AND THEIR USE European Patent17784795.1Filed on 2017-10-03
Stabilized Group 2 Influenza Hemagglutinin Stem Region Trimers and Uses Thereof Read more about Stabilized Group 2 Influenza Hemagglutinin Stem Region Trimers and Uses Thereof Singapore11201901790YFiled on 2017-09-01
Stabilized Group 2 Influenza Hemagglutinin Stem Region Trimers and Uses Thereof Read more about Stabilized Group 2 Influenza Hemagglutinin Stem Region Trimers and Uses Thereof Japan2019-512267Filed on 2017-09-01
Stabilized Group 2 Influenza Hemagglutinin Stem Region Trimers and Uses Thereof Read more about Stabilized Group 2 Influenza Hemagglutinin Stem Region Trimers and Uses Thereof South Korea10-2019-7009334Filed on 2019-04-01
Stabilized Group 2 Influenza Hemagglutinin Stem Region Trimers and Uses Thereof Read more about Stabilized Group 2 Influenza Hemagglutinin Stem Region Trimers and Uses Thereof Israel265121Filed on 2017-09-01
Stabilized Group 2 Influenza Hemagglutinin Stem Region Trimers and Uses Thereof Read more about Stabilized Group 2 Influenza Hemagglutinin Stem Region Trimers and Uses Thereof BrazilBR112019004189-3Filed on 2017-09-01
Stabilized Group 2 Influenza Hemagglutinin Stem Region Trimers and Uses Thereof Read more about Stabilized Group 2 Influenza Hemagglutinin Stem Region Trimers and Uses Thereof Australia2017321883Filed on 2019-03-27
CHIMERIC VECTORS Read more about CHIMERIC VECTORS Patent Cooperation TreatyPCT/US2019/028771Filed on 2019-04-23
VACCINE CANDIDATES FOR HUMAN RESPIRATORY SYNCYTIAL VIRUS (RSV) HAVING ATTENUATED PHENOTYPES Read more about VACCINE CANDIDATES FOR HUMAN RESPIRATORY SYNCYTIAL VIRUS (RSV) HAVING ATTENUATED PHENOTYPES US Patent 10,808,012Filed on 2019-03-20